‘Longevity drug’ rapamycin may have a surprising impact on exercise
The Washington Post • • general
Key Points:
- A recent study found that rapamycin, a drug used by many Americans for longevity, may reduce some of the health benefits typically gained from exercise.
- Rapamycin is FDA-approved to prevent organ-transplant rejection but has gained popularity off-label for its potential lifespan-extending effects observed in yeast, flies, and mice.
- Researchers initially expected rapamycin to enhance exercise benefits and provide additional health improvements, but the study’s findings contradicted these expectations.
